Used for excision of the urinary bladder.
Temporary or permanent diversion of the flow of urine through the ureter away from the URINARY BLADDER in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. (From Campbell's Urology, 6th ed, p2654)
Tumors or cancer of the URINARY BLADDER.
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Structures which collect and store urine and are emptied by catheterization of a cutaneous stoma or internal diversion to the urethra. The reservoirs are surgically created during procedures for urinary diversion.
General term for CYSTS and cystic diseases of the OVARY.
Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.
Surgical formation of an opening in the ureter for external drainage of the urine; cutaneous route utilizes a ureteral orifice emerging through the skin.
An embryonic structure originating from the ALLANTOIS. It is a canal connecting the fetal URINARY BLADDER and the UMBILICUS. It is normally converted into a fibrous cord postnatally. When the canal fails to be filled and remains open (patent urachus), urine leaks through the umbilicus.
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.
A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.
A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
The epithelial lining of the URINARY TRACT.
Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
Techniques, procedures, and therapies carried out on diseased organs in such a way to avoid complete removal of the organ and preserve the remaining organ function.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
Endoscopic examination, therapy or surgery of the urinary bladder.
The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.
Surgery performed on the urinary tract or its parts in the male or female. For surgery of the male genitalia, UROLOGIC SURGICAL PROCEDURES, MALE is available.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.
A uroplakin subtype that heterodimerizes with UROPLAKIN IA to form a component of the asymmetric unit membrane found in urothelial cells.
The duration of a surgical procedure in hours and minutes.
Pathological processes of the OVARY.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
Excision of one or both of the FALLOPIAN TUBES.
A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.
Distention of KIDNEY with the presence of PUS and suppurative destruction of the renal parenchyma. It is often associated with renal obstruction and can lead to total or nearly total loss of renal function.
Tumors or cancer of the URINARY TRACT in either the male or the female.
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Endoscopic examination, therapy or surgery of the female pelvic viscera by means of an endoscope introduced into the pelvic cavity through the posterior vaginal fornix.
One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.
Liver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles (HYDATID CYST).
A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. (Stedman, 25th ed)
Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.
Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. (1/407)

Recent studies have shown that patients whose bladder cancer exhibit overexpression of RB protein as measured by immunohistochemical analysis do equally poorly as those with loss of RB function. We hypothesized that loss of p16 protein function could be related to RB overexpression, since p16 can induce transcriptional downregulation of RB and its loss may lead to aberrant RB regulation. Conversely, loss of RB function has been associated with high p16 protein expression in several other tumor types. In the present study RB negative bladder tumors also exhibited strong nuclear p16 staining while each tumor with strong, homogeneous RB nuclear staining were p16 negative, supporting our hypothesis. To expand on these immunohistochemical studies additional cases were selected in which the status of the p16 encoding gene had been determined at the molecular level. Absent p16 and high RB protein expression was found in the tumors having loss of heterozygosity within 9p21 and a structural change (mutation or deletion) of the remaining p16 encoding gene allele, confirming the staining results. These results strongly support the hypothesis that the RB nuclear overexpression recently associated with poor prognosis in bladder cancer is also associated with loss of p16 function and implies that loss of p16 function could be equally deleterious as RB loss in bladder and likely other cancers.  (+info)

Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. (2/407)

Here, we present a novel strategy for dissecting some of the steps involved in the squamous differentiation of the bladder urothelium leading to squamous cell carcinomas (SCCs). First, we used proteomic technologies and databases (http://biobase.dk/cgi-bin/celis) to reveal proteins that were expressed specifically by fresh normal urothelium and three SCCs showing no urothelial components. Thereafter, antibodies against some of the differentially expressed proteins as well as a few known keratinocyte markers were used to stain serial cryostat sections (immunowalking) of biopsies obtained from bladder cystectomies of two of the SCC-bearing patients (884-1 and 864-1). Because bladder cancer is a field disease, we surmised that the urothelium of these patients may exhibit a spectrum of abnormalities ranging from early metaplastic stages to invasive disease. Immunohistochemical analysis revealed three types of non-keratinizing metaplastic lesions (types 1-3) that did not express keratins 7, 8, 18, and 20 (expressed by normal urothelium) and could be distinguished based on their staining with keratin 19 antibodies. Type 1 lesions showed staining of all cell layers in the epithelium (with differences in the staining intensity of the basal compartment), whereas type 2 lesions exhibited mainly basal cell staining. Type 3 lesions did not stain with keratin 19 antibodies. In cystectomy 884-1, type 3 lesions exhibited the same immunophenotype as the SCC and may be regarded as precursors to the tumor. Basal cells in these lesions did not express keratin 13, suggesting that the tumor, which was also keratin 13 negative, may have arisen from the expansion of these cells. Similar results were observed with cystectomy 864-1, which showed carcinoma in situ of the SCC type. SCC 864-1 exhibited both keratin 19-negative and -positive cells, implying that the tumor arose from the expansion of the basal cell compartment of type 2 and 3 lesions. Besides providing with a novel strategy for revealing metaplastic lesions, our studies have shown that it is feasible to apply powerful proteomic technologies to the analysis of complex biological samples under conditions that are as close as possible to the in vivo situation.  (+info)

Modification of the Kock's pouch for bladder replacement. (3/407)

AIM: To describe a modification of the Kock's pouch and present our clinical experience in its application. METHOD: After isolating an adequate ileal segment, the bowel is split by a longitudinal incision, with both ends remaining unopened for about 3-4 cm in length. Previously anastomozed ureters are inserted into the proximal end so that a nipple valve is created. The distal unsplit end serves for a direct anastomosis with the urethra. During the past 9 years, this surgery was performed in 41 patients who underwent radical cystectomy due to invasive carcinoma. Seventeen patients died for unknown reasons or were lost to follow-up. The remaining 24 were included in the follow-up for a period of 7 months to 6 years post surgery. RESULTS: Half of the patients included in the follow-up urinated spontaneously, with post void residuals less than 120 mL and no need for catheterization. Four patients did not urinate spontaneously and needed continuos catheterization, whereas 8 patients had post void residuals of 150-200 mL and needed catheterization once a day or once a week. None of the patients had a stricture at the site of ureteroileal anastomosis. CONCLUSION: We believe that our modification of the Kock's pouch makes the uretero-intestinal anastomosis much easier to perform; both ureters are inserted into the unsplit bowel end, thus preventing reflux; anastomosis with the urethra is performed under visual control; and direct anastomosis of widely opened distal end of the bowel reduces the possibility of scar stenosis.  (+info)

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer. (4/407)

This study was undertaken to evaluate the risk of haematogenous dissemination of epithelial cells induced by endoscopic resection and/or cystoprostatectomy for transitional cell carcinoma of the bladder. Thirty-three patients were studied. Thirty-one had different stages and grades of bladder cancer and two patients had benign bladder conditions. Twenty-five cancer patients required transurethral resection of their bladder tumour. Of those, 20 had superficial disease (pTaG1-G2: n = 19; pT1G2: n = 1) and five had muscle invasive tumours (pT2G3: n = 2; pT3aG3: n = 1; pT4G3: n = 2). Five patients underwent radical cystoprostatectomy for muscle invasive cancers (pT2G3: n = 3; pT3bG3: n = 1; pT4G3: n = 1) and one man received chemotherapy for metastatic disease. Venous blood (10 ml) was obtained from the antecubital fossa in each patient, before and 1-2 h after completion of surgery, and prior to treatment in the metastatic patient. An indirect immunocytochemical technique was used to detect circulating epithelial cells after centrifugation on Ficoll gradient and fixation of mononuclear cells on slides, using a monoclonal antibody directed against three cytokeratins: CK8, CK18 and CK19. Circulating epithelial cells were detected only in the patient with metastatic disease. None of the other patients had evidence of epithelial circulating cells before or after surgery. The results suggest that irrespective of disease stage and grade, neither endoscopic nor open bladder surgery leads to detectable dissemination of urothelial cells in the peripheral circulation. These procedures are therefore unlikely to increase the risk of progression and metastasis in transitional cell carcinoma of the bladder.  (+info)

Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. (5/407)

PURPOSE: The role of postchemotherapy surgery for patients with metastatic transitional cell carcinoma (TCC) is controversial. We retrospectively analyzed our experience with patients who underwent postchemotherapy surgery after methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) chemotherapy to assess an impact on long-term survival. PATIENTS AND METHODS: This report is based on the retrospective analysis of 203 patients with unresectable primary tumors or metastatic TCC, previously reported in five trials of M-VAC chemotherapy. Fifty patients underwent postchemotherapy surgery for suspected or known residual disease. Characteristics of patients selected for surgery, results of surgery, and the impact of surgery on survival were assessed. RESULTS: In 17 patients, no viable tumor was found at postchemotherapy surgery, pathologically confirming a complete response to chemotherapy. Three patients had unresectable residual TCC. In 30 patients, residual, viable TCC was completely resected, which resulted in a complete response to chemotherapy plus surgery. Ten (33%) of these 30 patients remained alive at 5 years, similar to results observed for patients who attained a complete response to chemotherapy alone (41%). Analysis by baseline extent of disease suggested that patients with unresectable primary tumors or with metastases restricted to lymph node sites were most likely to survive for 5 years. CONCLUSION: Postchemotherapy surgical resection of residual cancer may result in 5-year disease-free survival in some patients who would otherwise succumb to disease. Optimal candidates include patients whose prechemotherapy sites of disease are restricted to the primary or lymph node sites and who have a major response to chemotherapy.  (+info)

Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder. (6/407)

BACKGROUND: The possibility of bladder preservation as well as the utility of neo-adjuvant chemotherapy for invasive bladder cancer are controversial issues. The purpose of this study was the evaluation of neo-adjuvant M-VAC chemotherapy and bladder preservation in patients with locally advanced transitional cell carcinoma of the bladder. PATIENTS AND METHODS: Eighty-seven consecutive evaluable patients with T2-T4aNxM0 TCC of the bladder were treated with three cycles of neo-adjuvant M-VAC chemotherapy. After three cycles of M-VAC, 42 patients had TURB alone, 13 patients underwent partial cystectomy, and 32 patients were to undergo radical cystectomy. RESULTS: Forty (51%) patients were T0 at the TURB following M-VAC. Thirty (71%) patients who had chemotherapy and TURB alone are alive; at a median follow-up of 54+ months (8(+)-109+). Twenty-four (57%) have maintained an intact bladder. Of 13 responding patients with monofocal lesions who underwent partial cystectomy, 8 patients (62%) are alive with a functioning bladder, at a median follow-up of 80+ months (16-107+ months). At a follow-up of 32 months (7-121+ months), 20 (63%) patients in the radical cystectomy group are alive. In patients who had downstaging to T0 or superficial disease, median follow-up is 55 months (10-121+ months) and five-year survival is 71%. Patients who failed to respond (T2 or greater after chemotherapy), at a median follow-up of 24 months (7-103+ months), had five-year survival of only 29%. CONCLUSIONS: Bladder sparing in selected patients on the basis of response to neo-adjuvant chemotherapy is a feasible approach which must be confirmed in prospective randomized trials.  (+info)

Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. (7/407)

We compared the grading and staging of transurethral resection of the bladder (TURB) and cystectomy specimens for 105 patients who underwent radical cystectomy for urothelial carcinoma between 1980 and 1984. Of 105 patients, 96% underwent cystectomy within 100 days of TURB (median interval, 10 days). Grading was performed according to the 1998 World Health Organization/International Society of Urologic Pathology grading system and staging according to the 1997 TNM classification. Histologic grade was low-grade, 13; high-grade, 92 in TURB specimens; low-grade, 17; high-grade, 88 in cystectomy specimens. Pathologic stage was Ta, 15; T1, 55; and T2, 35 in TURB specimens; Ta, 5; T1, 19; T2, 19; T3, 46; and T4, 16 in cystectomy specimens. Histologic grade at TURB was associated with pathologic stage at cystectomy (P < .001). When all advanced-stage (muscle-invasive) carcinomas (pT2 or more) were considered together, 55 patients were understaged by TURB, 4 had higher stage in TURB than in cystectomy, and 46 were the same stage as by cystectomy. Forty-three of 55 patients with stage T1 carcinoma at TURB had advanced-stage carcinoma at cystectomy, including 34 who had extravesicular extension (pT3 or more). We found pathologic understanding by TURB occurs in a significant number of patients with bladder cancer; the newly proposed grading system predicted final pathologic stage.  (+info)

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. (8/407)

BACKGROUND: Radical cystectomy is the standard treatment for patients with muscle invasive bladder cancer. Three to four cycles of adjuvant chemotherapy is widely used in patients with pT3-pT4a and/or pN+ M0 disease in an effort to delay recurrence and prolong survival. Although a number of clinical trials have been carried out, this paper questions whether the use of adjuvant combination chemotherapy is actually justified. PATIENTS AND METHODS: A review of published randomized trials of adjuvant cisplatin-containing combination chemotherapy in locally advanced bladder cancer was undertaken. Four trials including a total of 278 randomized patients were identified. RESULTS: Although these trials appear to show a significant difference in favor of adjuvant chemotherapy, serious methodological flaws were found. They have major deficiencies in terms of sample size, early stopping of patient entry, statistical analyses, reporting of results and drawing conclusions. CONCLUSIONS: These trials provide insufficient evidence to support the routine use of adjuvant chemotherapy in clinical practice due to small sample sizes, confusing analyses and terminology, and the reporting of questionable conclusions. Analyses of the duration of survival were either not done or were inconclusive and quality of life has not been considered. New large scale, multicenter trials are imperative in order to provide convincing results.  (+info)

Cystectomy is a surgical procedure in which all or part of the urinary bladder is removed. This procedure is often used to treat bladder cancer, but it may also be necessary in cases of severe bladder damage, infection, or inflammation that do not respond to other treatments.

There are several types of cystectomy, including:

1. Radical cystectomy: This is the most common type of cystectomy performed for bladder cancer. It involves removing the entire bladder, as well as nearby lymph nodes, the prostate gland in men, and the uterus, ovaries, fallopian tubes, and a portion of the vagina in women.
2. Partial cystectomy: In this procedure, only a part of the bladder is removed. This may be an option for patients with early-stage bladder cancer that has not spread deeply into the bladder muscle or to other parts of the body.
3. Urinary diversion: After a cystectomy, the surgeon must create a new way for urine to leave the body. This may involve creating a urostomy, in which a piece of intestine is used to form a stoma (an opening) on the abdominal wall, through which urine can be collected in a bag. Alternatively, the surgeon may create an internal pouch using a segment of intestine, which can then be connected to the ureters and allowed to drain into the rectum or vagina.

As with any surgical procedure, cystectomy carries risks such as bleeding, infection, and reactions to anesthesia. Patients may also experience long-term complications such as urinary incontinence, sexual dysfunction, and changes in bowel habits. However, for many patients with bladder cancer or other severe bladder conditions, cystectomy can be a life-saving procedure.

Urinary diversion is a surgical procedure that involves the creation of a new way for urine to leave the body, bypassing the native urinary system. This is typically performed in individuals who have damaged or removed urinary systems due to conditions such as cancer, severe trauma, or congenital abnormalities.

There are several types of urinary diversions, including:

1. Ileal Conduit: A segment of the small intestine (ileum) is used to create a passageway for urine to flow from the ureters to an external collection bag or pouch worn on the abdomen.
2. Continent Urinary Reservoir: A pouch-like reservoir is created using a segment of the intestine, which is then connected to the ureters. The patient periodically empties the reservoir through a stoma (opening) in the abdominal wall using a catheter.
3. Orthotopic Neobladder: A pouch-like reservoir is created using a segment of the intestine, which is then connected to the urethra, allowing for normal urination through the native urethral opening.

These procedures can significantly improve the quality of life for patients with severe urinary system damage or disease, although they do come with potential complications such as infections, stone formation, and electrolyte imbalances.

Urinary Bladder Neoplasms are abnormal growths or tumors in the urinary bladder, which can be benign (non-cancerous) or malignant (cancerous). Malignant neoplasms can be further classified into various types of bladder cancer, such as urothelial carcinoma, squamous cell carcinoma, and adenocarcinoma. These malignant tumors often invade surrounding tissues and organs, potentially spreading to other parts of the body (metastasis), which can lead to serious health consequences if not detected and treated promptly and effectively.

Transitional cell carcinoma (TCC) is a type of cancer that develops in the transitional epithelium, which is the tissue that lines the inner surface of the urinary tract. This includes the renal pelvis, ureters, bladder, and urethra. Transitional cell carcinoma is the most common type of bladder cancer and can also occur in other parts of the urinary system.

Transitional cells are specialized epithelial cells that can stretch and change shape as the organs they line expand or contract. These cells normally have a flat, squamous appearance when at rest but become more cuboidal and columnar when the organ is full. Transitional cell carcinomas typically start in the urothelium, which is the innermost lining of the urinary tract.

Transitional cell carcinoma can be classified as non-invasive (also called papillary or superficial), invasive, or both. Non-invasive TCCs are confined to the urothelium and have not grown into the underlying connective tissue. Invasive TCCs have grown through the urothelium and invaded the lamina propria (a layer of connective tissue beneath the urothelium) or the muscle wall of the bladder.

Transitional cell carcinoma can also be categorized as low-grade or high-grade, depending on how abnormal the cancer cells look under a microscope and how likely they are to grow and spread. Low-grade TCCs tend to have a better prognosis than high-grade TCCs.

Treatment for transitional cell carcinoma depends on the stage and grade of the cancer, as well as other factors such as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, or immunotherapy.

Continent urinary reservoirs refer to an artificial bladder or storage system that is created to store urine in individuals with bladder dysfunction or those who have undergone bladder removal. These reservoirs are implanted inside the body and are designed to provide continence, which means they prevent leakage of urine until a patient decides to empty it.

Continent urinary reservoirs can be created using different techniques and materials, such as small intestine or stomach tissue, which are fashioned into a pouch-like structure. A stoma or opening is created in the abdominal wall through which the reservoir can be periodically drained using a catheter.

These types of urinary diversions are typically recommended for patients who cannot undergo more conventional forms of urinary reconstruction, such as bladder augmentation or neobladder construction, due to various medical reasons. Continent urinary reservoirs offer several advantages over incontinent urinary diversions, including improved quality of life, greater social acceptance, and reduced risk of skin irritation and dehydration. However, they also require regular catheterization and careful monitoring to ensure proper functioning and prevent complications such as infection or stone formation.

An ovarian cyst is a sac or pouch filled with fluid that forms on the ovary. Ovarian cysts are quite common in women during their childbearing years, and they often cause no symptoms. In most cases, ovarian cysts disappear without treatment over a few months. However, larger or persistent cysts may require medical intervention, including surgical removal.

There are various types of ovarian cysts, such as functional cysts (follicular and corpus luteum cysts), which develop during the menstrual cycle due to hormonal changes, and non-functional cysts (dermoid cysts, endometriomas, and cystadenomas), which can form due to different causes.

While many ovarian cysts are benign, some may have malignant potential or indicate an underlying medical condition like polycystic ovary syndrome (PCOS). Regular gynecological check-ups, including pelvic examinations and ultrasounds, can help detect and monitor ovarian cysts.

Muscle neoplasms are abnormal growths or tumors that develop in the muscle tissue. They can be benign (non-cancerous) or malignant (cancerous). Benign muscle neoplasms are typically slow-growing and do not spread to other parts of the body, while malignant muscle neoplasms, also known as soft tissue sarcomas, can grow quickly, invade nearby tissues, and metastasize (spread) to distant parts of the body.

Soft tissue sarcomas can arise from any of the muscles in the body, including the skeletal muscles (voluntary muscles that attach to bones and help with movement), smooth muscles (involuntary muscles found in the walls of blood vessels, digestive tract, and other organs), or cardiac muscle (the specialized muscle found in the heart).

There are many different types of soft tissue sarcomas, each with its own set of characteristics and prognosis. Treatment for muscle neoplasms typically involves a combination of surgery, radiation therapy, and chemotherapy, depending on the type, size, location, and stage of the tumor.

Ureterostomy is a surgical procedure that creates an opening from one or both ureters, the tubes that carry urine from the kidneys to the bladder, to the abdominal wall. This allows urine to bypass the bladder and be expelled through the opening, called a stoma, into a collection device or onto the skin where it can be absorbed by a pad or diaper.

Ureterostomy is typically performed as a temporary measure in cases of severe bladder injury, infection, or obstruction that cannot be immediately corrected. It may also be used as a permanent solution for patients with congenital abnormalities or conditions that prevent the normal flow of urine through the bladder.

There are two main types of ureterostomy: cutaneous and uretero-cutanoeostomy. In a cutaneous ureterostomy, the ureter is brought directly to the abdominal wall and sutured in place. In a uretero-cutanoeostomy, a piece of intestine is used to create a conduit between the ureter and the abdominal wall.

Like any surgical procedure, ureterostomy carries risks such as bleeding, infection, and injury to surrounding organs. Patients who undergo this procedure will require close monitoring and follow-up care to ensure proper healing and function of the stoma.

The urachus is a vestigial structure in humans, which is a fibrous cord that connects the umbilicus (navel or belly button) to the dome-shaped top of the bladder. In fetal development, the urachus is the passageway for urine to move from the developing bladder to the allantois, an outpouching of the hindgut that ultimately becomes part of the placenta.

After birth, the urachus usually obliterates and turns into a fibrous cord called the median umbilical ligament. However, in some cases, the urachus may not completely obliterate, leading to various congenital abnormalities such as urachal cysts, urachal sinuses, or urachal fistulas. These conditions can cause symptoms like lower abdominal pain, infection, and sometimes even sepsis if left untreated.

It's worth noting that the urachus is not a commonly discussed structure in routine medical practice, but it does have clinical significance in certain pediatric surgical cases and congenital anomalies.

Urethral neoplasms refer to abnormal growths or tumors in the urethra, which is the tube that carries urine from the bladder out of the body. These growths can be benign (non-cancerous) or malignant (cancerous).

Benign urethral neoplasms may include conditions such as urethral polyps or papillomas, which are usually not life-threatening and can often be removed with surgery.

Malignant urethral neoplasms, on the other hand, are cancerous tumors that can invade surrounding tissues and spread to other parts of the body. These include urethral carcinomas, which can be further classified into different types such as squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, depending on the type of cells involved.

Urethral neoplasms are relatively rare, but when they do occur, they can cause a variety of symptoms such as difficulty urinating, blood in the urine, pain during urination or sexual intercourse, and discharge from the urethra. Treatment options depend on the type, location, and stage of the neoplasm, and may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Laparoscopy is a surgical procedure that involves the insertion of a laparoscope, which is a thin tube with a light and camera attached to it, through small incisions in the abdomen. This allows the surgeon to view the internal organs without making large incisions. It's commonly used to diagnose and treat various conditions such as endometriosis, ovarian cysts, infertility, and appendicitis. The advantages of laparoscopy over traditional open surgery include smaller incisions, less pain, shorter hospital stays, and quicker recovery times.

The urinary bladder is a muscular, hollow organ in the pelvis that stores urine before it is released from the body. It expands as it fills with urine and contracts when emptying. The typical adult bladder can hold between 400 to 600 milliliters of urine for about 2-5 hours before the urge to urinate occurs. The wall of the bladder contains several layers, including a mucous membrane, a layer of smooth muscle (detrusor muscle), and an outer fibrous adventitia. The muscles of the bladder neck and urethra remain contracted to prevent leakage of urine during filling, and they relax during voiding to allow the urine to flow out through the urethra.

Robotics, in the medical context, refers to the branch of technology that deals with the design, construction, operation, and application of robots in medical fields. These machines are capable of performing a variety of tasks that can aid or replicate human actions, often with high precision and accuracy. They can be used for various medical applications such as surgery, rehabilitation, prosthetics, patient care, and diagnostics. Surgical robotics, for example, allows surgeons to perform complex procedures with increased dexterity, control, and reduced fatigue, while minimizing invasiveness and improving patient outcomes.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Urothelium is the specialized type of epithelial tissue that lines the urinary tract, including the renal pelvis, ureters, bladder, and urethra. It is a type of transitional epithelium that can change its shape and size depending on the degree of distension or stretching of the organs it lines.

The main function of urothelium is to provide a barrier against urine, which contains various waste products and potential irritants, while also allowing the exchange of ions and water. The urothelial cells are joined together by tight junctions that prevent the passage of substances through the paracellular space, and they also have the ability to transport ions and water through their cell membranes.

In addition to its barrier function, urothelium is also involved in sensory and immune functions. It contains specialized nerve endings that can detect mechanical and chemical stimuli, such as stretch or irritation, and it expresses various antimicrobial peptides and other defense mechanisms that help protect the urinary tract from infection.

Overall, urothelium plays a critical role in maintaining the health and function of the urinary tract, and its dysfunction has been implicated in various urinary tract disorders, such as interstitial cystitis/bladder pain syndrome and bladder cancer.

Lymph node excision is a surgical procedure in which one or more lymph nodes are removed from the body for the purpose of examination. This procedure is often conducted to help diagnose or stage various types of cancer, as malignant cells may spread to the lymphatic system and eventually accumulate within nearby lymph nodes.

During a lymph node excision, an incision is made in the skin overlying the affected lymph node(s). The surgeon carefully dissects the tissue surrounding the lymph node(s) to isolate them from adjacent structures before removing them. In some cases, a sentinel lymph node biopsy may be performed instead, where only the sentinel lymph node (the first lymph node to which cancer cells are likely to spread) is removed and examined.

The excised lymph nodes are then sent to a laboratory for histopathological examination, which involves staining and microscopic evaluation of the tissue to determine whether it contains any malignant cells. The results of this examination can help guide further treatment decisions and provide valuable prognostic information.

Organ sparing treatments refer to medical interventions that are designed to preserve the structure and function of an organ, while still effectively treating the underlying disease or condition. These treatments can include surgical techniques, radiation therapy, or medications that aim to target specific cells or processes involved in the disease, while minimizing damage to healthy tissues.

Organ sparing treatments may be used in a variety of medical contexts, such as cancer treatment, where the goal is to eliminate malignant cells while preserving as much normal tissue as possible. For example, radiation therapy may be delivered with precise techniques that limit exposure to surrounding organs, or medications may be used to target specific receptors on cancer cells, reducing the need for more extensive surgical interventions.

Similarly, in the context of kidney disease, organ sparing treatments may include medications that help control blood pressure and reduce proteinuria (protein in the urine), which can help slow the progression of kidney damage and potentially delay or prevent the need for dialysis or transplantation.

Overall, organ sparing treatments represent an important area of medical research and practice, as they offer the potential to improve patient outcomes, reduce treatment-related morbidity, and maintain quality of life.

Neoplasm invasiveness is a term used in pathology and oncology to describe the aggressive behavior of cancer cells as they invade surrounding tissues and organs. This process involves the loss of cell-to-cell adhesion, increased motility and migration, and the ability of cancer cells to degrade the extracellular matrix (ECM) through the production of enzymes such as matrix metalloproteinases (MMPs).

Invasive neoplasms are cancers that have spread beyond the original site where they first developed and have infiltrated adjacent tissues or structures. This is in contrast to non-invasive or in situ neoplasms, which are confined to the epithelial layer where they originated and have not yet invaded the underlying basement membrane.

The invasiveness of a neoplasm is an important prognostic factor in cancer diagnosis and treatment, as it can indicate the likelihood of metastasis and the potential effectiveness of various therapies. In general, more invasive cancers are associated with worse outcomes and require more aggressive treatment approaches.

Cystoscopy is a medical procedure that involves the insertion of a thin, flexible tube with a camera and light on the end (cystoscope) into the bladder through the urethra. This procedure allows healthcare professionals to examine the lining of the bladder and urethra for any abnormalities such as inflammation, tumors, or stones. Cystoscopy can be used for diagnostic purposes, as well as for therapeutic interventions like removing small bladder tumors or performing biopsies. It is typically performed under local or general anesthesia to minimize discomfort and pain.

The pelvis is the lower part of the trunk, located between the abdomen and the lower limbs. It is formed by the fusion of several bones: the ilium, ischium, and pubis (which together form the hip bone on each side), and the sacrum and coccyx in the back. The pelvis has several functions including supporting the weight of the upper body when sitting, protecting the lower abdominal organs, and providing attachment for muscles that enable movement of the lower limbs. In addition, it serves as a bony canal through which the reproductive and digestive tracts pass. The pelvic cavity contains several vital organs such as the bladder, parts of the large intestine, and in females, the uterus, ovaries, and fallopian tubes.

Urologic surgical procedures refer to various types of surgeries that are performed on the urinary system and male reproductive system. These surgeries can be invasive (requiring an incision) or minimally invasive (using small incisions or scopes). They may be performed to treat a range of conditions, including but not limited to:

1. Kidney stones: Procedures such as shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy are used to remove or break up kidney stones.
2. Urinary tract obstructions: Surgeries like pyeloplasty and urethral dilation can be done to correct blockages in the urinary tract.
3. Prostate gland issues: Transurethral resection of the prostate (TURP), simple prostatectomy, and robotic-assisted laparoscopic radical prostatectomy are some procedures used for benign prostatic hyperplasia (BPH) or prostate cancer.
4. Bladder problems: Procedures such as cystectomy (removal of the bladder), bladder augmentation, and implantation of an artificial urinary sphincter can be done for conditions like bladder cancer or incontinence.
5. Kidney diseases: Nephrectomy (removal of a kidney) may be necessary for severe kidney damage or cancer.
6. Testicular issues: Orchiectomy (removal of one or both testicles) can be performed for testicular cancer.
7. Pelvic organ prolapse: Surgeries like sacrocolpopexy and vaginal vault suspension can help correct this condition in women.

These are just a few examples; there are many other urologic surgical procedures available to treat various conditions affecting the urinary and reproductive systems.

Neoplasm staging is a systematic process used in medicine to describe the extent of spread of a cancer, including the size and location of the original (primary) tumor and whether it has metastasized (spread) to other parts of the body. The most widely accepted system for this purpose is the TNM classification system developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).

In this system, T stands for tumor, and it describes the size and extent of the primary tumor. N stands for nodes, and it indicates whether the cancer has spread to nearby lymph nodes. M stands for metastasis, and it shows whether the cancer has spread to distant parts of the body.

Each letter is followed by a number that provides more details about the extent of the disease. For example, a T1N0M0 cancer means that the primary tumor is small and has not spread to nearby lymph nodes or distant sites. The higher the numbers, the more advanced the cancer.

Staging helps doctors determine the most appropriate treatment for each patient and estimate the patient's prognosis. It is an essential tool for communication among members of the healthcare team and for comparing outcomes of treatments in clinical trials.

Intravesical administration refers to the instillation of medication directly into the bladder through a catheter or other medical device. This method is often used to deliver treatments for various bladder conditions, such as interstitial cystitis, bladder cancer, and chronic bladder infections. The medication is held in the bladder for a specified period, usually ranging from a few minutes to several hours, before being urinated out. This allows the medication to come into close contact with the bladder lining, potentially enhancing its effectiveness while minimizing systemic side effects.

Uroplakin II is a type of protein that is a component of the urothelium, which is the tissue that lines the urinary tract. Specifically, uroplakins are part of the asymmetric unit membrane (AUM) of the urothelial plaques, which are specialized structures on the apical surface of the urothelium. These plaques help to provide a barrier function and protect the underlying tissues from various harmful substances in the urine. Uroplakin II is a transmembrane protein that forms heterodimers with other uroplakins, such as uroplakin Ib, to create the building blocks of the urothelial plaques.

Operative time, in medical terms, refers to the duration from when an incision is made in the surgical procedure until the closure of the incision. This period includes any additional time needed for re-exploration or reopening during the same operation. It does not include any time spent performing other procedures that may be necessary but are carried out at a later stage. Operative time is an essential metric used in surgery to assess efficiency, plan resources, and determine costs.

Ovarian diseases refer to a range of conditions that affect the function and health of the ovaries, which are the female reproductive organs responsible for producing eggs (oocytes) and female hormones estrogen and progesterone. These diseases can be categorized into functional disorders, infectious and inflammatory diseases, neoplastic diseases, and other conditions that impact ovarian function. Here's a brief overview of some common ovarian diseases:

1. Functional Disorders: These are conditions where the ovaries experience hormonal imbalances or abnormal functioning, leading to issues such as:
* Polycystic Ovary Syndrome (PCOS): A condition characterized by hormonal imbalances that can cause irregular periods, cysts in the ovaries, and symptoms like acne, weight gain, and infertility.
* Functional Cysts: Fluid-filled sacs that develop within the ovary, usually as a result of normal ovulation (follicular or corpus luteum cysts). They're typically harmless and resolve on their own within a few weeks or months.
2. Infectious and Inflammatory Diseases: These conditions are caused by infections or inflammation affecting the ovaries, such as:
* Pelvic Inflammatory Disease (PID): An infection that spreads to the reproductive organs, including the ovaries, fallopian tubes, and uterus. It's often caused by sexually transmitted bacteria like Chlamydia trachomatis or Neisseria gonorrhoeae.
* Tuberculosis (TB): A bacterial infection that can spread to the ovaries and cause inflammation, abscesses, or scarring.
3. Neoplastic Diseases: These are conditions where abnormal growths or tumors develop in the ovaries, which can be benign (non-cancerous) or malignant (cancerous). Examples include:
* Ovarian Cysts: While some cysts are functional and harmless, others can be neoplastic. Benign tumors like fibromas, dermoids, or cystadenomas can grow significantly larger and cause symptoms like pain or bloating. Malignant tumors include epithelial ovarian cancer, germ cell tumors, and sex cord-stromal tumors.
4. Other Conditions: Various other conditions can affect the ovaries, such as:
* Polycystic Ovary Syndrome (PCOS): A hormonal disorder that causes enlarged ovaries with small cysts. It's associated with irregular periods, infertility, and increased risk of diabetes, high blood pressure, and heart disease.
* Premature Ovarian Failure (POF): Also known as primary ovarian insufficiency, it occurs when the ovaries stop functioning before age 40, leading to menstrual irregularities, infertility, and early onset of menopause.

It's essential to consult a healthcare professional if you experience any symptoms related to your reproductive system or suspect an issue with your ovaries. Early detection and treatment can significantly improve the prognosis for many conditions affecting the ovaries.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Local neoplasm recurrence is the return or regrowth of a tumor in the same location where it was originally removed or treated. This means that cancer cells have survived the initial treatment and started to grow again in the same area. It's essential to monitor and detect any local recurrence as early as possible, as it can affect the prognosis and may require additional treatment.

Salpingectomy is a surgical procedure in which one or both of the fallopian tubes are removed. These tubes are slender structures that connect the ovaries to the uterus, through which the egg travels from the ovary to the uterus during ovulation. Salpingectomy can be performed for various reasons such as ectopic pregnancy, salpingitis (inflammation of the fallopian tubes), hydrosalpinx (fluid-filled tube), or as a preventative measure in women with increased risk of ovarian cancer. The procedure can be carried out through laparoscopy, hysteroscopy, or laparotomy, depending on the patient's condition and the surgeon's preference.

Endometriosis is a medical condition in which tissue similar to the lining of the uterus (endometrium) grows outside the uterine cavity, most commonly on the ovaries, fallopian tubes, and the pelvic peritoneum. This misplaced endometrial tissue continues to act as it would inside the uterus, thickening, breaking down, and bleeding with each menstrual cycle. However, because it is outside the uterus, this blood and tissue have no way to exit the body and can lead to inflammation, scarring, and the formation of adhesions (tissue bands that bind organs together).

The symptoms of endometriosis may include pelvic pain, heavy menstrual periods, painful intercourse, and infertility. The exact cause of endometriosis is not known, but several theories have been proposed, including retrograde menstruation (the backflow of menstrual blood through the fallopian tubes into the pelvic cavity), genetic factors, and immune system dysfunction.

Endometriosis can be diagnosed through a combination of methods, such as medical history, physical examination, imaging tests like ultrasound or MRI, and laparoscopic surgery with tissue biopsy. Treatment options for endometriosis include pain management, hormonal therapies, and surgical intervention to remove the misplaced endometrial tissue. In severe cases, a hysterectomy (removal of the uterus) may be recommended, but this is typically considered a last resort due to its impact on fertility and quality of life.

Adjuvant chemotherapy is a medical treatment that is given in addition to the primary therapy, such as surgery or radiation, to increase the chances of a cure or to reduce the risk of recurrence in patients with cancer. It involves the use of chemicals (chemotherapeutic agents) to destroy any remaining cancer cells that may not have been removed by the primary treatment. This type of chemotherapy is typically given after the main treatment has been completed, and its goal is to kill any residual cancer cells that may be present in the body and reduce the risk of the cancer coming back. The specific drugs used and the duration of treatment will depend on the type and stage of cancer being treated.

Urology is a surgical specialty that deals with the diagnosis and treatment of diseases and conditions related to the male and female urinary tract system and the male reproductive organs. This includes the kidneys, ureters, bladder, prostate gland, and testicles. Urologists are medical doctors who have completed specialized training in this field, and they may perform various surgical procedures such as cystoscopy, lithotripsy, and radical prostatectomy to treat conditions like kidney stones, urinary tract infections, bladder cancer, enlarged prostate, and infertility.

Pyonephrosis is a medical condition characterized by the presence of pus in the renal pelvis, which is the part of the kidney where urine collects before flowing into the ureter. This occurs as a result of a severe infection that has spread to the kidney and caused pus to accumulate within the renal pelvis. Pyonephrosis can lead to serious complications such as sepsis, kidney damage, or even kidney failure if left untreated. It is typically treated with antibiotics and may require surgical intervention to drain the pus and remove any infected tissue.

Urologic neoplasms refer to abnormal growths or tumors in the urinary system, which includes the kidneys, ureters, bladder, prostate, and urethra. These growths can be benign (non-cancerous) or malignant (cancerous). Common types of urologic neoplasms include renal cell carcinoma, transitional cell carcinoma, bladder cancer, prostate cancer, and testicular cancer. It is important to note that early detection and treatment can significantly improve outcomes for patients with urologic neoplasms.

Neoadjuvant therapy is a treatment regimen that is administered to patients before they undergo definitive or curative surgery for their cancer. The main goal of neoadjuvant therapy is to reduce the size and extent of the tumor, making it easier to remove surgically and increasing the likelihood of complete resection. This type of therapy often involves the use of chemotherapy, radiation therapy, or targeted therapy, and it can help improve treatment outcomes by reducing the risk of recurrence and improving overall survival rates. Neoadjuvant therapy is commonly used in the treatment of various types of cancer, including breast, lung, esophageal, rectal, and bladder cancer.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Culdoscopy is a medical procedure that involves the insertion of a laparoscope through the vagina and into the pelvic cavity, allowing the medical professional to visually examine the organs in the area, such as the ovaries, fallopian tubes, and uterus. The procedure is typically used for diagnostic purposes, such as to investigate the cause of pelvic pain or abnormal bleeding, or to guide surgical procedures. It is not a commonly performed procedure due to the development of other less invasive techniques, such as transvaginal ultrasound and pelvic laparoscopy.

A ureter is a thin, muscular tube that transports urine from the kidney to the bladder. In humans, there are two ureters, one for each kidney, and they are typically about 10-12 inches long. The ureters are lined with a special type of cells called transitional epithelium that can stretch and expand as urine passes through them. They are located in the retroperitoneal space, which is the area behind the peritoneum, the membrane that lines the abdominal cavity. The ureters play a critical role in the urinary system by ensuring that urine flows from the kidneys to the bladder for storage and eventual elimination from the body.

Echinococcosis, hepatic is a type of parasitic infection caused by the larval stage of the tapeworm Echinococcus granulosus. The infection typically occurs when a person accidentally ingests microscopic eggs of the tapeworm, which can be present in contaminated food, water, or soil.

Once inside the body, the eggs hatch and release larvae that can migrate to various organs, including the liver. In the liver, the larvae form hydatid cysts, which are fluid-filled sacs that can grow slowly over several years, causing symptoms such as abdominal pain, nausea, vomiting, and jaundice.

Hepatic echinococcosis is a serious condition that can lead to complications such as cyst rupture, infection, or organ damage if left untreated. Treatment options include surgery to remove the cysts, medication to kill the parasites, or a combination of both. Prevention measures include good hygiene practices, avoiding contact with contaminated soil or water, and cooking meat thoroughly before eating it.

A dermoid cyst is a type of benign (non-cancerous) growth that typically develops during embryonic development. It is a congenital condition, which means it is present at birth, although it may not become apparent until later in life. Dermoid cysts are most commonly found in the skin or the ovaries of women, but they can also occur in other areas of the body, such as the spine or the brain.

Dermoid cysts form when cells that are destined to develop into skin and its associated structures, such as hair follicles and sweat glands, become trapped during fetal development. These cells continue to grow and multiply, forming a sac-like structure that contains various types of tissue, including skin, fat, hair, and sometimes even teeth or bone.

Dermoid cysts are usually slow-growing and may not cause any symptoms unless they become infected or rupture. In some cases, they may cause pain or discomfort if they press on nearby structures. Treatment typically involves surgical removal of the cyst to prevent complications and alleviate symptoms.

Disease-free survival (DFS) is a term used in medical research and clinical practice, particularly in the field of oncology. It refers to the length of time after primary treatment for a cancer during which no evidence of the disease can be found. This means that the patient shows no signs or symptoms of the cancer, and any imaging studies or other tests do not reveal any tumors or other indications of the disease.

DFS is often used as an important endpoint in clinical trials to evaluate the effectiveness of different treatments for cancer. By measuring the length of time until the cancer recurs or a new cancer develops, researchers can get a better sense of how well a particular treatment is working and whether it is improving patient outcomes.

It's important to note that DFS is not the same as overall survival (OS), which refers to the length of time from primary treatment until death from any cause. While DFS can provide valuable information about the effectiveness of cancer treatments, it does not necessarily reflect the impact of those treatments on patients' overall survival.

Vinblastine is an alkaloid derived from the Madagascar periwinkle plant (Catharanthus roseus) and is primarily used in cancer chemotherapy. It is classified as a vinca alkaloid, along with vincristine, vinorelbine, and others.

Medically, vinblastine is an antimicrotubule agent that binds to tubulin, a protein involved in the formation of microtubules during cell division. By binding to tubulin, vinblastine prevents the assembly of microtubules, which are essential for mitosis (cell division). This leads to the inhibition of cell division and ultimately results in the death of rapidly dividing cells, such as cancer cells.

Vinblastine is used to treat various types of cancers, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, breast cancer, and others. It is often administered intravenously in a healthcare setting and may be given as part of a combination chemotherapy regimen with other anticancer drugs.

As with any medication, vinblastine can have side effects, including bone marrow suppression (leading to an increased risk of infection, anemia, and bleeding), neurotoxicity (resulting in peripheral neuropathy, constipation, and jaw pain), nausea, vomiting, hair loss, and mouth sores. Regular monitoring by a healthcare professional is necessary during vinblastine treatment to manage side effects and ensure the safe and effective use of this medication.

Two main types of cystectomies can be performed. A partial cystectomy (also known as a segmental cystectomy) involves removal ... Radical cystectomy is the recommended treatment for bladder cancer that has invaded the muscle of the bladder. Cystectomy may ... A minimally invasive radical cystectomy more commonly known as a robot-assisted laparoscopic radical cystectomy (RARC) may be ... Generally, there are no specific contraindications to having a cystectomy. However, cystectomy should not be performed in ...
Cystectomy is an inadequate approach. The Sistrunk procedure is the surgical resection of the central portion of the hyoid bone ... and simple cystectomy treatment modalities. The Sistrunk procedure also showed better outcomes concerning the rate of overall ...
Kuffel, A; Kapitza, KP; Löwe, B; Eichelberg, E; Gumz, A (October 2014). "[Chronic pollakiuria: cystectomy or psychotherapy]". ...
Scherr was the first physician at Cornell to perform a robotic prostatectomy as well as a robotic cystectomy. A native of New ... Oncological Outcomes of Robotic Cystectomy. San Francisco, CA August, 2007. Raman, JD; Sosa, RE; Vaughan Ed, Jr; Scherr, DS ( ... Wang, GJ; Barocas, DA; Raman, JD; Scherr, DS (2008). "Robotic vs open radical cystectomy: prospective comparison of ...
Ghoneim MA, Adhmallah AK, Awaad HK, et al.; "Cystectomy & Diversion for Carcinoma of the Bilharzial Bladder;" 1988; Progressive ...
The procedure combines a cystectomy and a urethrectomy.[citation needed] List of surgeries by type "NCI Dictionary of Cancer ...
Cystectomy is the removal of the urinary bladder. It also means removal of a cyst. Corpectomy is the removal of a vertebral ...
The procedure combines a cystectomy and a prostatectomy. List of surgeries by type Berglund, Ryan K (16 October 2021). " ...
It is usually used in conjunction with radical cystectomy in order to control invasive bladder cancer. To create an ileal ... Sorcini, A; Tuerk, I (2004). "Laparoscopic radical cystectomy with ileal conduit urinary diversion". Urologic Oncology: ...
"Immediate Versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the ... Immediate Versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the ... Immediate Versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the ... "3. This trial demonstrated the value of adjuvant chemotherapy after cystectomy. A meta-analysis showed that overall there is ...
Zhao T, Liu Y, Wang X, Zhang H, Lu Y (April 2017). "Ovarian cystectomy in the treatment of apparent early-stage immature ... Some physicians recommend ovarian cystectomy alone, rather than a unilateral salpingo-oophorectomy for patients with an early ...
"Robotic-assisted Laparoscopic Radical Cystectomy with Extracorporeal Urinary Diversion: Initial Experience". European Urology. ...
Menon, the VUI established the first ever robotic training program in the world; for prostatectomy in 2000, for cystectomy in ... "Robotic radical cystectomy and urinary diversion in the management of bladder cancer". Urologic Clinics of North America. 31 (4 ...
... analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy ... Robotic surgery has also been utilized in radical cystectomies. A 2013 review found less complications and better short term ...
In 1889 Austrian gynecologist Karl Pawlik performed a successful cystectomy on a patient suffering from papillomatosis of the ... Bardenheuer specialized in genitourinary surgery, and in 1887 performed the first complete cystectomy. This operation involved ...
"Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer". New England ... Neoadjuvant chemotherapy (NAC) followed by a radical cystectomy (RC) and pelvic lymph node dissection is current standard of ... "Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy". The Journal of Urology: 1903- ... "Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic ...
A cystectomy is the removal of a cyst followed by mucosa and wound closure to reduce chances of cyst regeneration. This type of ... Resolution of this type of cyst requires surgical treatment such as a cystectomy. Periapical pocket cysts - epithelium lined ... Surgical options for previously treated teeth that would not benefit from root canal therapy include cystectomy and cystostomy ...
Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: Initial experience and outcomes, PMID ... "Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: Initial experience and outcomes". Indian ...
Bonney was a strong proponent for organ-conservation, including preserving the ovaries using techniques in ovarian cystectomy ... With Comyns Berkeley and Douglas Macleod) The Technical Minutiae of Extended Myomectomy and Ovarian Cystectomy. Cassell, London ... with Comyns Berkeley and The Technical Minutiae of extended Myomectomy and Ovarian Cystectomy (1946). He took lessons at a ... Bonney towards conservative surgery and he became a pioneer in the field of the less drastic procedures of ovarian cystectomy ...
These have included training in cystectomy and creation of a neobladder in Mansoura in Egypt. Teaching of robotic laparoscopy ...
Bilateral versus unilateral cystectomy of endometriomas can reduce ovarian reserve, as well as recurrent endometrioma excisions ... No difference has been found between surgery (cystectomy or aspiration) versus expectant management, or between ablation versus ... cystectomy, prior to IVF in women with endometriosis. Utilizing IVF procedures prior to endometriosis-associated surgery has ...
There is a rare occurrence of a pelvic recurrence of a low-grade superficial TCC after cystectomy. Delayed presentation with ...
... is most commonly performed after cystectomy, such as may be necessary in, for example, bladder cancer. Other ...
The system has been used in the following procedures: Radical prostatectomy, pyeloplasty, cystectomy, nephrectomy and ureteral ...
... the role of cystectomy and splenic preservation: experience with seven consecutive patients". J Trauma. 35 (3): 430-6. doi: ...
... partial cystectomy) or all (radical cystectomy) of the bladder is removed (a cystectomy) and the urinary stream is diverted ... August 2003). "Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer". ... July 2013). "Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy ... a partial cystectomy with lymphadenectomy can be considered. Management plan including partial cystectomy should be accompanied ...
... and Laparoscopic Radical Cystectomy (CORAL)". European Urology. 69 (4): 613-621. doi:10.1016/j.eururo.2015.07.038. ISSN 1873- ...
In August 1889 he performed the first successful cystectomy on a patient suffering from papillomatosis of the bladder. He is ...
"Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the ...
Radical prostatectomy and radical cystectomy both require anastomosis of the bladder to the urethra in order to restore ...
Two main types of cystectomies can be performed. A partial cystectomy (also known as a segmental cystectomy) involves removal ... Radical cystectomy is the recommended treatment for bladder cancer that has invaded the muscle of the bladder. Cystectomy may ... A minimally invasive radical cystectomy more commonly known as a robot-assisted laparoscopic radical cystectomy (RARC) may be ... Generally, there are no specific contraindications to having a cystectomy. However, cystectomy should not be performed in ...
Pilonidal cystectomy may vary from a simple procedure that involves excision of a small amount of tissue to a very complex ... Background Pilonidal cystectomy is the surgical removal of a pilonidal cyst or tracts extending from a sinus. ... encoded search term (Pilonidal Cystectomy) and Pilonidal Cystectomy What to Read Next on Medscape ... Pilonidal Cystectomy Periprocedural Care. Updated: Jun 01, 2023 * Author: Ramon A Riojas, MD, PhD; Chief Editor: Erik D Schraga ...
I was diagnosed last month with adenocarcinoma of the bladder and am looking ahead to the radical cystectomy that is going to ... Replied by Plk on topic Radical Cystectomy Options? I will be having a radical cystectomy with an Indiana Pouch on October 5. ... Replied by LillianG on topic Radical Cystectomy Options? Plk, I just want to wish you smooth sailing through your surgery on 10 ... Replied by sara.anne on topic Radical Cystectomy Options? We will all be thinking of you and wishing you the very bestt! Please ...
Laparospopic Ovarian Cystectomy. Please click here to return to the Patient Video Library. ...
Laparoscopic Cholecystectomy and Hydatid Cystectomy. In the world of modern medicine, surgery has advanced by leaps and bounds ... Hydatid Cystectomy:**. Hydatid cystectomy, unlike laparoscopic cholecystectomy, is a procedure tailored to address hydatid ... Hydatid Cystectomy:**. 1. **Definitive Treatment:** Hydatid cystectomy offers a definitive solution for patients suffering from ... Advantages of Laparoscopic Cholecystectomy and Hydatid Cystectomy**. Laparoscopic cholecystectomy and hydatid cystectomy are ...
Rates of adherence to post-radical cystectomy surveillance guidelines in real-world practice have been as low as 9%. ... "Reported rates of adherence to post-radical cystectomy surveillance guidelines in real-world practice have been as low as 9%, ... Adherence to post-radical cystectomy (RC) surveillance guidelines may prove to be lifesaving for some patients, according to a ... Is there value to routine oncologic surveillance after radical cystectomy? Comparative outcomes of symptomatic versus ...
Patients undergoing radical cystectomy frequently suffer from infectious complications, including urinary tract infections ( ... Time to stent removal ranged from 4 to 25 d after cystectomy. Prophylactic antibiotics were used before stent removal in nine ... Patients undergoing radical cystectomy frequently suffer from infectious complications, including urinary tract infections ( ... We confirmed a high proportion of infectious complications after cystectomy, and a heterogeneous pattern of choice and duration ...
blcwebcafe.org/cystectomy.asp , He lives in the Kansas City, Missouri area and is really interested in talking with someone in ... Replied by Terri_S. on topic My Dad is having a radical cystectomy ... Replied by KarenE on topic My Dad is having a radical cystectomy ... My Dad is having a radical cystectomy My Dad is having a ... Replied by wendy on topic My Dad is having a radical cystectomy ... Replied by wendy on topic My Dad is having a radical cystectomy ...
Robotic cystectomy is not inferior to open cystectomy in terms of 2-year progression-free and overall survival. Robotic ...
Keywords: endometrioma, anti-mullerian hormone, cystectomy, cyst size Citation styles. APA Copy. Anh, N.D., Ha, N.T.T., Tri, N. ... Long-Term Follow-Up Of Anti-Mullerian Hormone Levels After Laparoscopic Endometrioma Cystectomy. Int J Med Sci 2022; 19(4):651- ... Long-Term Follow-Up Of Anti-Mullerian Hormone Levels After Laparoscopic Endometrioma Cystectomy. Int J Med Sci 2022; 19(4):651- ... Long-Term Follow-Up Of Anti-Mullerian Hormone Levels After Laparoscopic Endometrioma Cystectomy. Int J Med Sci. 19(4):651-658. ...
... is one of the most common complications after laparoscopic radical cystectomy (LRC). Albeit its high incidence, its risk ... Postoperative ileus (POI) is one of the most common complications after laparoscopic radical cystectomy (LRC). Albeit its high ... Risk factors of postoperative ileus following laparoscopic radical cystectomy and developing a points-based risk assessment ...
The 30-day all-cause mortality rate was 0.9% for robot-assisted radical cystectomy vs 1.5% for open radical cystectomy (odds ... Compared with open radical cystectomy, robot-assisted radical cystectomy was associated with:. *Lower estimated blood loss ( ... Among 889 patients undergoing robot-assisted radical cystectomy and 2,280 undergoing open radical cystectomy, a propensity ... in the robot-assisted radical cystectomy group vs 30.2% (variance = 1.59%) in the open radical cystectomy group at 5 years, and ...
Objective: To evaluate long-term follow-up results of ERAS concepts in patients undergoing radical cystectomy for bladder ... For patients undergoing radical cystectomy, prospective data are still rare. In the year 2014, our group could prove ... Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced ...
Brief Title: Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy. ... Neoadjuvant Intravesical NIS Measles Virus (MV-NIS) in Patients Undergoing Cystectomy for Urothelial Carcinoma But Ineligible ... in patients with urothelial carcinoma who are undergoing radical cystectomy but are ineligible or do not desire neoadjuvant ... indication for Radical cystectomy (RC); ineligibility for platinum-based neoadjuvant chemotherapy ...
Should I trust a regular OB GYN to do a Laparoscopic Cystectomy on an 8.4 and 4 cm hypoechoic cystic lesion? Or should I have a ... I am scheduled for laparoscopic ovarian cystectomy in 7 days and on the day of surgery, it will possibly be my last day of the ... Laparoscopic bilateral ovarian cystectomy can affect sex life?. 1 doctor answer • 4 doctors weighed in ... I am having laparoscopic cystectomy surgery, how long should i take off work?. 2 doctor answers • 3 doctors weighed in ...
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy Projekter: Projekt › ...
The Canadian Journal of Urology, (CJU), is the only peer reviewed, indexed, scientific urology journal published in Canada. It is published six times per year and is available on MEDLINE. The journal has steadily gained recognition in the medical community within Canada and abroad, and continues to successfully disseminate the latest scientific knowledge in the field of urology.
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients ... PURPOSE: Preoperative chemotherapy is underused in conjunction with radical cystectomy (RC) for muscle-invasive bladder cancer ... Bladder cancer, Induction chemotherapy, Neoadjuvant chemotherapy, Postoperative complications, Radical cystectomy National ... We identified 1,340 patients who underwent RC between 2011 and 2015 in Sweden due to MIBC according to the Swedish Cystectomy ...
Radical cystectomy (RC) remains the gold standard treatment for patients with muscle-invasive bladder cancer. Unfortunately, a ... Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy ...
Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer ... POSTOPERATIVE COMPLICATIONS; ANTIMICROBIAL PROPHYLAXIS; ILEAL; RISK; DIVERSION; Urinary tract infection; Cystectomy; Antibiotic ... and the clinical risk factors of UTI in a multi-institutional cohort of patients who had undergone radical cystectomy (RC). ... and the clinical risk factors of UTI in a multi-institutional cohort of patients who had undergone radical cystectomy (RC). ...
Get Estimated Price for Laparoscopic Ovarian Cystectomy Unilateral at top hospitals and book an instant appointment on ... Laparoscopic Ovarian Cystectomy Unilateral Cost in Delhi NCR. ... Get Cost of Laparoscopic Ovarian Cystectomy Unilateral in Delhi ... Laparoscopic Ovarian Cystectomy Unilateral Cost in India Laparoscopic Ovarian Cystectomy Unilateral Cost in Mumbai Laparoscopic ... Laparoscopic Ovarian Cystectomy Unilateral Cost in Kolkata Laparoscopic Ovarian Cystectomy Unilateral Cost in Chennai ...
... and cystectomy for muscle-invasive tumors..., from the online textbook of urology by D. Manski ... Radical cystectomy; orthotopic urinary diversion is not possible.. Alternatives to cystectomy:. Alternatives to cystectomy ... Partial Cystectomy. Partial cystectomy with pelvic lymphadenectomy is a therapeutic alternative to radical cystectomy for ... After cystectomy with R0, N0, M0:. Regular cancer follow-up.. After cystectomy with R1, N+ or ≥T3b:. Consider adjuvant ...
Factors influencing ICU admission and associated outcomes in patients undergoing radical cystectomy with enhanced recovery ... "Factors influencing ICU admission and associated outcomes in patients undergoing radical cystectomy with enhanced recovery ... Factors influencing ICU admission and associated outcomes in patients undergoing radical cystectomy with enhanced recovery ... "Factors influencing ICU admission and associated outcomes in patients undergoing radical cystectomy with enhanced recovery ...
Our results revealed that several clinicopathological characteristics can predict CSS risk after radical cystectomy. ... further confirm the predictive value of these variables for the prognosis of bladder cancer patients after radical cystectomy. ... significance of specific clinicopathological features plays an important role in surgical management after radical cystectomy. ... Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the international robotic cystectomy ...
keywords = "Bladder cancer, Complications, Cystectomy, Open radical cystectomy, Quality of life, Radical cystectomy, Robot- ... Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, ... Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, ... Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, ...
... Healthy Lifestyle Blog , Health News , Public Health , Meddco ... Ovarian Cystectomy laparoscopic An ovarian cystectomy Laparoscopic surgery is a type of minimally invasive surgery that ... What happens during the Ovarian Cystectomy laparoscopic?. You will be put to sleep with anaesthesia prior to the surgery. A ... What Can I Expect Following Ovarian Cystectomy laparoscopic?. You can resume normal activities within a day of having an ...
An Ovarian Cystectomy almost always is done with a minimally invasive procedure that involves small skin incisions, using ... Ovarian cystectomy requires an experienced surgeon that could minimize the damage to healthy ovarian tissues during the ... An Ovarian Cystectomy is the removal of ovarian cysts or tumors, while still preserving the ovaries. ...
Are you looking for a specialist in the field of Cystectomy? Here you will find selected specialists in Germany, Austria or ... Cystectomy. Cystectomy You are looking for an experienced medical specialist in the field of Cystectomy? At PRIMO MEDICO you ... Information About the Field of Cystectomy. Someone in need of a doctor prefers the best medical care as possible. Thats why ... All doctors and clinics listed here have been checked by us for their outstanding specialization in the area of Cystectomy. ...
Cystectomy with Neobladder Reconstruction Schedule An Appointment Saint Johns: A Legacy of Care Excellence - 30 Major ...
When is Cystectomy necessary?. Ημερομηνία-ώρα: Saturday, April 12, 2008 - 18:00 to 19:00 ...
  • Cystectomy is a medical term for surgical removal of all or part of the urinary bladder. (wikipedia.org)
  • A partial cystectomy (also known as a segmental cystectomy) involves removal of only a portion of the bladder. (wikipedia.org)
  • A radical cystectomy involves removal of the entire bladder along with surrounding lymph nodes and other nearby organs that contain cancer. (wikipedia.org)
  • Radical cystectomy is the recommended treatment for bladder cancer that has invaded the muscle of the bladder. (wikipedia.org)
  • A partial cystectomy involves removal of only a portion of the bladder and is performed for some benign and malignant tumors localized to the bladder. (wikipedia.org)
  • Individuals that may be candidates for partial cystectomy include those with single tumors located near the dome, or top, of the bladder, tumors that do not invade the muscle of the bladder, tumors located within bladder diverticulum, or cancer that is not carcinoma in situ (CIS). (wikipedia.org)
  • A radical cystectomy is most commonly performed for cancer that has invaded into the muscle of the bladder. (wikipedia.org)
  • In a radical cystectomy the bladder is removed along with surrounding lymph nodes (lymph node dissection) and other organs that contain cancer. (wikipedia.org)
  • A minimally invasive radical cystectomy more commonly known as a robot-assisted laparoscopic radical cystectomy (RARC) may be an option for individuals depending on several factors including but not limited to: their overall health (with special attention to their lung health), body mass index (BMI), number and types of previous surgeries, along with the location and size of the bladder cancer. (wikipedia.org)
  • In a Swedish population-based cohort study reported in JAMA Network Open , Mortezavi et al found that robot-assisted radical cystectomy with intracorporeal urinary diversion was associated with reduced all-cause mortality, reduced high-grade complications, and improved perioperative outcomes vs open radical cystectomy in patients with bladder cancer. (ascopost.com)
  • The study involved data from the Swedish National Register of Urinary Bladder Cancer and population-based Cause of Death Register on all patients who underwent radical cystectomy for bladder cancer between January 2011 and December 2018, with follow-up data collected through December 2019. (ascopost.com)
  • Objective: To evaluate long-term follow-up results of ERAS concepts in patients undergoing radical cystectomy for bladder cancer. (uni-muenchen.de)
  • Odd sensation in bladder when coming towards end of urination, 2 weeks after laparoscopic ovarian cystectomy, why is this? (healthtap.com)
  • Preoperative chemotherapy is underused in conjunction with radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC) due to concerns for complications and delay of surgery. (diva-portal.org)
  • Radical cystectomy (RC) remains the gold standard treatment for patients with muscle-invasive bladder cancer. (canjurol.com)
  • The aim of resection is the complete removal of the tumor manifestation, for this purpose the tumor is either resected in fractions (standard method) or dissected en bloc with tumor base from the bladder wall. (urology-textbook.com)
  • Prospective studies are needed to further confirm the predictive value of these variables for the prognosis of bladder cancer patients after radical cystectomy. (biomedcentral.com)
  • Context: Differences in recovery, oncological, and quality of life (QoL) outcomes between open radical cystectomy (ORC) and robot-assisted radical cystectomy (RARC) for patients with bladder cancer are unclear. (herts.ac.uk)
  • Radical and partial cystectomy are surgical procedures that are performed to remove part or all of the bladder in order to treat bladder cancer. (txhospitals.in)
  • If you have bladder cancer or cancer that has spread from other areas into your bladder, you may need a radical cystectomy. (bladdercancer.net)
  • Radical cystectomy is a type of surgery where doctors remove your bladder and surrounding lymph nodes. (bladdercancer.net)
  • A radical cystectomy is complicated since your surgeon will need to move several organs in your belly around to remove your bladder. (bladdercancer.net)
  • Cystectomy is the procedure to remove all or part of the bladder. (somerseturological.com)
  • Partial cystectomy is the removal of only part of the bladder. (somerseturological.com)
  • Partial cystectomy is possible only if the cancer is not near the openings where urine enters or leaves the bladder. (somerseturological.com)
  • Radical cystectomy is the removal of the entire bladder, nearby lymph nodes, part of the urethra, and nearby organs that may contain cancer cells. (somerseturological.com)
  • And today he is going to talk to us about a recent publication from a study of his that talks about a very, very important thing for our patients, which is, their quality of life after surgery for bladder cancer, essentially, a radical cystectomy in this case. (urotoday.review)
  • Simple cystectomy: bladder removal. (pagniurologia.it)
  • As mentioned, in selected cases and in general for non-tumor pathologies, the removal can be limited to the bladder alone without removing the prostate, the seminal vesicles and the urethra in the man (superpullary cystectomy) or uterus and annexed in the woman. (pagniurologia.it)
  • After bladder removal (cystectomy) the gastrointestinal tract most suitable for urinary derivation will be identified and isolated. (pagniurologia.it)
  • INTRODUCTION & OBJECTIVES: Robot- assisted radical cystectomy is a widespread minimally invasive technique for the treatment of muscle-invasive and organ-limited bladder cancer in selected patients. (unifi.it)
  • CONCLUSIONS: Recent systematic reviews of literature reported that robot-assisted radical cystectomy with totally intracorporeal ileal bladder reconstruction represents a valid alternative to open surgery in selected patients with muscle-infiltrant bladder cancer. (unifi.it)
  • In the current study, we demonstrated the technical feasibility of the robotassisted radical cystectomy with totally intracorporeal ileal bladder reconstruction at our Institution. (unifi.it)
  • Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy? (endourology.ph)
  • Imaging characteristics in bladder cancer (BC), such as hydronephrosis, are predictive of ≥ pT3 disease at time of radical cystectomy (RC). (endourology.ph)
  • If the cancer is larger or has spread deeper into the bladder, a surgeon can perform a cystectomy, removing the whole bladder or just the cancerous tissue. (medicalnewstoday.com)
  • Associations of self-efficacy, social support and coping strategies with health-related quality of life after radical cystectomy for bladder cancer: A cross-sectional study. (bvsalud.org)
  • Investigating associations between self - efficacy , social support and quality of life ( HRQoL ) and mediating effects of coping among bladder cancer (BC) patients treated with radical cystectomy (RC). (bvsalud.org)
  • There are no established biomarkers to guide patient selection for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer. (lu.se)
  • Larger studies of QoL among patients operated with total cystectomy in comparison with partial bladder resection are lacking. (lu.se)
  • I will be having a radical cystectomy with an Indiana Pouch on October 5. (bladdercancersupport.org)
  • Dr. Bochner highlights a number of factors that can be affected by having a radical cystectomy which is a significant surgery. (urotoday.review)
  • In an open radical cystectomy a large incision is made in the middle of the abdomen from just above or next to the umbilicus to the pubic symphysis. (wikipedia.org)
  • Among 889 patients undergoing robot-assisted radical cystectomy and 2,280 undergoing open radical cystectomy, a propensity score-matched cohort of 874 robot-assisted radical cystectomy patients and 1,154 open radical cystectomy patients was used for analysis. (ascopost.com)
  • Cancer-specific mortality rates were 27.6% (variance = 3.12%) in the robot-assisted radical cystectomy group vs 30.2% (variance = 1.59%) in the open radical cystectomy group at 5 years, and 30.3% (variance = 5.13%) vs 32.3% (variance = 1.91%) at 7 years ( P = .16). (ascopost.com)
  • The 30-day all-cause mortality rate was 0.9% for robot-assisted radical cystectomy vs 1.5% for open radical cystectomy (odds ratio [OR] = 0.58, 95% CI = 0.15-2.28, P = .44) and the 90-day mortality rate was 2.7% vs 4.2% (OR = 0.70, 95% CI = 0.32-1.54, P = .38). (ascopost.com)
  • However, robot-assisted radical cystectomy was associated with a higher 90-day rehospitalization rate vs open radical cystectomy (34.3% vs 26.1%, OR = 1.28, 95% CI = 1.02-1.60, P = .03). (ascopost.com)
  • The investigators concluded, "These findings suggest that compared with open radical cystectomy, robot-assisted radical cystectomy with intracorporeal urinary diversion was associated with a lower overall mortality rate, fewer high-grade complications, and more favorable perioperative outcomes. (ascopost.com)
  • Objectives: To assess the rate of urinary tract infection (UTI), the characteristics of the bacterial aetiological agents involved, the type and duration of antibiotics used, and the clinical risk factors of UTI in a multi-institutional cohort of patients who had undergone radical cystectomy (RC). (uni-regensburg.de)
  • Patients who have undergone radical cystectomy require routine surveillance to monitor for local recurrence or the development of metastatic disease. (medscape.com)
  • There's been a variety of quality of life studies in people that have undergone radical cystectomy but many of the studies have used sort of snapshot approaches to look at specific time points following surgery. (urotoday.review)
  • Patients undergoing radical cystectomy frequently suffer from infectious complications, including urinary tract infections (UTIs) and surgical site infections (SSIs) leading to emergency department visits, hospital readmission, and added cost. (urotoday.com)
  • For patients undergoing radical cystectomy, prospective data are still rare. (uni-muenchen.de)
  • This is a Phase 1 study designed to test the tolerability and feasibility of intravesical therapy with an attenuated Measles virus (MV-NIS) in patients with urothelial carcinoma who are undergoing radical cystectomy but are ineligible or do not desire neoadjuvant chemotherapy. (bcan.org)
  • Cheng KW, Shah A, Nassiri N, Ghodoussipour S, Miranda G, Cai J, Daneshmand S, Schuckman A, Djaladat H. Factors influencing ICU admission and associated outcomes in patients undergoing radical cystectomy with enhanced recovery pathway . (duke.edu)
  • Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review. (urotoday.com)
  • To summarize the literature regarding perioperative antibiotic prophylaxis, ureteric stent usage, and prevalence of infectious complications after cystectomy. (urotoday.com)
  • We confirmed a high proportion of infectious complications after cystectomy, and a heterogeneous pattern of choice and duration of antibiotics during and after surgery or stent removal. (urotoday.com)
  • Postoperative ileus (POI) is one of the most common complications after laparoscopic radical cystectomy (LRC). (urotoday.com)
  • This nation-wide population-based observational study does not suggest that preoperative chemotherapy, in a setting with high utilisation of such treatment, is associated with an increased risk of short-term complications in MIBC patients treated with radical cystectomy. (diva-portal.org)
  • Scholars@Duke publication: Avoiding complications with radical cystectomy. (duke.edu)
  • What are the possible complications of a radical cystectomy? (bladdercancer.net)
  • An ovarian cystectomy Laparoscopic surgery is a type of minimally invasive surgery that requires only a few small incisions in your lower abdomen. (meddco.com)
  • A laparoscopic cystectomy procedure is a minimally invasive surgery during which a laparoscope, a long thin instrument with a camera attached at one end, is used. (gramercygynecology.com)
  • Laparoscopic ovarian cystectomy is a minimally invasive surgery to remove cysts. (nikrock.com)
  • Contact a local company to learn more about minimally invasive surgery options like laparoscopic ovarian cystectomy. (nikrock.com)
  • Risk factors of postoperative ileus following laparoscopic radical cystectomy and developing a points-based risk assessment scale. (urotoday.com)
  • A partial cystectomy may also be performed for removal of tumors which have originated and spread from neighboring organs such as the colon. (wikipedia.org)
  • Partial cystectomy with pelvic lymph node dissection. (urology-textbook.com)
  • In general, radical cystectomy can take anywhere from 4 to 8 hours, while partial cystectomy can take 2 to 4 hours. (txhospitals.in)
  • Radical and partial cystectomy are major surgeries that can have significant physical and emotional impacts on the patient. (txhospitals.in)
  • There are two types of cystectomy, partial and radical. (somerseturological.com)
  • Oncologic outcomes are worse among patients who experience symptomatic recurrence following radical cystectomy, study investigators reported. (renalandurologynews.com)
  • Compared to open surgery, minimally invasive radical cystectomy probably requires fewer blood transfusions and may shorten hospital stay slightly. (wikipedia.org)
  • I am having laparoscopic cystectomy surgery, how long should i take off work? (healthtap.com)
  • Intraoperative cyst rupture at laparoscopic ovarian cystectomy occurs more frequently than at laparotomy surgery. (intlwomensclinic.com)
  • A cystectomy is a major surgery and requires a lot of consideration. (somerseturological.com)
  • Cystectomy is a surgical procedure during which the ovarian cyst is removed either with laparoscopy or open surgery. (gramercygynecology.com)
  • surgery with cystectomy or oophorectomy is done if the mass is symptomatic or cancer is suspected. (msdmanuals.com)
  • The patient underwent radical cystectomy with an orthotopic neobladder. (cdc.gov)
  • Robotic cystectomy is not inferior to open cystectomy in terms of 2-year progression-free and overall survival. (urologytimes.com)
  • Robotic cystectomy was associated with increased soft tissue margins, however. (urologytimes.com)
  • An Ovarian Cystectomy almost always is done with a minimally invasive procedure that involves small skin incisions, using laparoscopic or robotic techniques. (gabymoawad.com)
  • However, cystectomy should not be performed in individuals who are not healthy enough to undergo a major surgical procedure. (wikipedia.org)
  • Hydatid cystectomy, unlike laparoscopic cholecystectomy, is a procedure tailored to address hydatid cysts, which develop as a result of parasitic infection, typically in the liver or lungs. (laparoscopyhospital.com)
  • Ovarian cystectomy requires an experienced surgeon that could minimize the damage to healthy ovarian tissues during the procedure and minimize the damage to the ovary. (gabymoawad.com)
  • Ovarian cystectomy is a surgical procedure that is intended to remove one or more cysts from one or both of the ovaries. (intlwomensclinic.com)
  • Laparoscopic ovarian cystectomy is a surgical procedure to remove cysts from the ovaries laparoscopically. (gramercygynecology.com)
  • Undergoing this procedure after a cystectomy can help provide a new way for the body to store and remove urine. (medicalnewstoday.com)
  • Radical cystectomy (RC) with bilateral pelvic lymph node dissection is the gold standard for patients with localized muscle-invasive tumors. (biomedcentral.com)
  • MATERIAL & METHODS: Between February and October 2016, three consecutive robot -assisted radical cystectomy with extended pelvic lymphadenectomy and totally intracorporeal ileal Neobladder reconstructions were performed at our Institution with an innovative surgical technique. (unifi.it)
  • In a prospective longitudinal study, 104 patients with unilateral (n=77) and bilateral (n=27) endometrioma underwent laparoscopic endometrioma cystectomy. (medsci.org)
  • Laparoscopic bilateral ovarian cystectomy can affect sex life? (healthtap.com)
  • An Ovarian Cystectomy is the removal of ovarian cysts or tumors, while still preserving the ovaries. (gabymoawad.com)
  • A cystectomy is the surgical treatment for the surgical removal of cysts that develop around the roots of the teeth and elsewhere in the jaws. (dentalpearls.gr)
  • On multivariate analysis, robot-assisted radical cystectomy was associated with significantly improved overall survival (hazard ratio = 0.71, 95% confidence interval [CI] = 0.56-0.89, P = .004). (ascopost.com)
  • A laparoscopic ovarian cystectomy involves the surgeon making a small incision in the bully button and near the pubic bone. (nikrock.com)
  • Evaluation of the tissue removed during cystectomy and lymph node dissection aids in determining pathological cancer staging. (wikipedia.org)
  • Cystectomy may also be recommended for individuals with a high risk of cancer progression or failure of the cancer to respond to less invasive treatments. (wikipedia.org)
  • Radical cystectomy: as the total, plus the removal of regional lymph nodes. (pagniurologia.it)
  • OBJECTIVE To identify the likelihood of finding one or more positive lymph nodes (LNs) according to the number of LNs removed at radical cystectomy (RC), as the number of LNs removed affects disease progression and survival after RC. (elsevierpure.com)
  • Some patients require additional follow-up care and treatment after the cystectomy including radiation therapy, chemotherapy, or immunotherapy. (somerseturological.com)
  • Because secondary lesions contraindicate cystectomy and require aggressive chemotherapy, we performed further investigations. (cdc.gov)
  • We identified 1,340 patients who underwent RC between 2011 and 2015 in Sweden due to MIBC according to the Swedish Cystectomy Register. (diva-portal.org)
  • Like all surgeries, radical cystectomy can cause further health problems. (bladdercancer.net)
  • An ovarian cystectomy can be performed via a laparoscopy or laparotomy under general anaesthesia. (intlwomensclinic.com)
  • And so what we wanted to do was just a large prospective, longitudinal study to really try to get a contemporary look at how patients do after radical cystectomy. (urotoday.review)
  • En-bloc resection is done with a monopolar hook, the resection loop, or the laser technique. (urology-textbook.com)
  • Adherence to post-radical cystectomy (RC) surveillance guidelines may prove to be lifesaving for some patients, according to a poster presentation at the virtual 2021 Genitourinary Cancers Symposium. (renalandurologynews.com)
  • Reported rates of adherence to post-radical cystectomy surveillance guidelines in real-world practice have been as low as 9%, in part reflecting a nihilistic view held by many of the value of routine follow-up. (renalandurologynews.com)
  • Is there value to routine oncologic surveillance after radical cystectomy? (renalandurologynews.com)
  • Risk-based surveillance strategies after cystectomy may streamline cost and efficacy. (urologytimes.com)
  • Some patients with more adverse pathology at the time of cystectomy (eg, locally advanced disease, lymph node metastases) may require more frequent imaging. (medscape.com)
  • It is also normal to go without a bowel movement in the days after a radical cystectomy. (bladdercancer.net)